NOT YET RECRUITING
NCT07692633
A Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults
The goal of this clinical trial is to assess the absorption, safety, and efficacy of an NAD+ supplement in healthy adults. The main question it aims to answer is: What is the change in NAD+ levels in whole blood from baseline to day 56 between the NAD+ supplement and placebo? Researchers will compare the NAD+ supplement to placebo to evaluate its absorption, safety, and efficacy. Participants will be asked to:
* Complete questionnaires
* Provide blood samples
* Consume either the NAD+ supplement or a placebo for 55 days
* Have their endothelial function evaluated
Gender: All
Ages: 40 Years - 65 Years
NAD+ Bioavailability
NAD+ Safety
NAD+ Efficacy